Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 2, 2007, Pages 94-98

  Kawagishi, Naoki ^a   Satoh, Kazushige ^a   Akamatsu, Yorihiro ^a   Sekiguchi, Satoshi ^a   Ishigaki, Yasushi ^a   Oikawa, Shinichi ^b   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Familial hypercholesterolemia; Heterozygous donor; Homozygous; Living donor liver transplantation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; INFANT; JAPAN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PARENT; PRESCHOOL CHILD; SIBLING; TIME;

ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HETEROZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; JAPAN; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PARENTS; SIBLINGS; TIME FACTORS;

EID: 34250619179     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14.94     Document Type: Article

References (12)

1. Naoumova RP, Thompson GR, and Soutar AK: Current management of severe homozygous hypercholesterolaemias. Curr Opin Lipidol, 2004; 15:413-422
2. Yamamoto A, Harada-Shiba M, Endo M, Kusakabe N, Tanioka T, Kato H, and Shoji T. The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy. Atherosclerosis, 2006; 186:126-131
3. Rader DJ: Gene therapy for familial hypercholesterolemia. Nutr Metab Cardiovasc Dis, 2001; 11 (Suppl. 5):40-44
4. Shirahata Y, Ohkohchi N, Kawagishi N, Syouji M, Tsukamoto S, Sekiguchi S, Koyamada N, Oikawa S, and Satomi S: Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int, 2003; 16:276-279
5. Francke U, Brown MS, and Goldstein JL: Assignment of the human gene for low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand and a genetic disease. Proc Natl Acad Sci USA, 1984; 81:2826-2830
6. Zschocke J and Schaefer JR: Homozygous familial hypercholesterolaemia in identical twins. Lancet, 2003; 361:1641
7. Starzl TE, Putnam CW, Chase HP, and Porter KA: Portcaval shunt in hyperlipoproteinemia. Lancet, 1973; 7835:940-944
8. Grossman M, Raper SE, and Kozarsky K: Successful ex vivo gene therapy directed to liver in a patient with familial hyper cholesterolemia. Nat Genet, 1994; 6:335-341
9. Starzl TE, Bilheimer DW, Bahnson HT, Shaw BW Jr, Hardesty RL, Griffith BP, Iwatsuki S, Zitelli BJ, Gartner JC Jr, and Malatack JJ: Heart-liver transplantation in a patient with familial hypercholesterolemia. Lancet, 1984; 8391:1382-1383
10. Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E, and Reznik Y: Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc, 2005; 37:2250-2252
11. Morioka D, Takada Y, Kasahara M, Ito T, Uryuhara K, Ogawa K, Egawa H, and Tanaka K: Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation, 2005; 80:623-628
12. Akabayashi A, Slingsby BT, and Fujita M: The first donor death after living-related liver transplantation in Japan. Transplantation, 2004; 77:634